Us-china Biomedical Technology, Revenue Growth Rates (CLDS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Us-china Biomedical Technology, Inc.  (CLDS)
    Sector • Services    Industry • Advertising
   Industry • Advertising
   Sector • Services
 

CLDS's Revenue Growth by Quarter and Year

Us-china Biomedical Technology,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLDS Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter February -
3rd Quarter November -
2nd Quarter August -
1st Quarter May 0.00
FY 0.00





CLDS Revenue first quarter 2020 Y/Y Growth Comment
Us-china Biomedical Technology, Inc. in the first quarter 2020 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2020, Us-china Biomedical Technology, Inc. achieved the best Revenue growth in Advertising industry. While Us-china Biomedical Technology, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2020.


CLDS Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter February - - - -
3rd Quarter November - - - -
2nd Quarter August - - - -
1st Quarter May - - - -
FY   - - - -

Financial Statements
Us-china Biomedical Technology,'s first quarter 2020 Revenue $ 0.00 millions CLDS's Income Statement
Us-china Biomedical Technology,'s first quarter 2019 Revenue $ 0.00 millions Quarterly CLDS's Income Statement


CLDS Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter February - - - -
3rd Quarter November - - - -
2nd Quarter August - - - -
1st Quarter May - - - -
FY (Year on Year)   - - - -


Back to CLDS Growth rate Comparisons >> Back to CLDS Growth rate Comparisons >>


Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Us-china Biomedical Technology,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's I. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CLDS's I. Quarter Q/Q Revenue Comment


Us-china Biomedical Technology,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2019)		 12 Months Ending
(Feb 28 2019)		 12 Months Ending
(Nov 30 2018)		 12 Months Ending
(Aug 31 2018)		 12 Months Ending
(May 31 2018)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the May 31 2019 period, Us-china Biomedical Technology,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the May 31 2019 period, Us-china Biomedical Technology,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Us-china Biomedical Technology, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Advertising Industry #
Services Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Advertising Industry Revenue Growth Trends and Statistics
Services Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLDS's Revenue Growth Ratio versus Advertising Industry, Services Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending May 31 2019 within Services SectorY/Y Change %Revenue for the quarter ending May 31 2019
Emmis Communications Corp-0.84%$ -0.839 millions
International Speedway Corporation-2.09%$ -2.094 millions
Starz Entertainment Corp -3.11%$ -3.107 millions
National American University Holdings, Inc.-4.60%$ -4.603 millions
Scholastic Corporation-5.14%$ -5.139 millions
Digital Brand Media And Marketing Group Inc-35.23%$ -35.234 millions
Davidstea Inc -50.77%$ -50.774 millions
Shiftpixy Inc -82.53%$ -82.529 millions
Transglobal Management Group Inc -83.90%$ -83.897 millions


About Us-china Biomedical Technology, Revenue Growth Rates (CLDS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.